Côte d'Ivoire vs Nigeria: Meningococcal A conjugate (MENGA) vaccine immunization coverage (%)
Côte d'Ivoire
51.0%
in 2025
Nigeria
53.0%
in 2025
Côte d'Ivoire rank
12th
Nigeria rank
11th
Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) over time
- Côte d'Ivoire
- Nigeria
How they compare
Nigeria currently reports 53.0% against 51.0% in Côte d'Ivoire, a difference of 2.0%.
The two have swapped places 2 times across 10 shared years of data; in 2016 it was Nigeria ahead.
Côte d'Ivoire ranks 12th and Nigeria ranks 11th of 26 countries.
Côte d'Ivoire has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Côte d'Ivoire | Nigeria | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 24.5% | 5.5% | 19.0% | Côte d'Ivoire |
| 2020s | 55.5% | 51.0% | 4.5% | Côte d'Ivoire |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher meningococcal a conjugate (menga) vaccine immunization coverage (%), Côte d'Ivoire or Nigeria?
- Nigeria, at 53.0% against 51.0% in Côte d'Ivoire as of 2025.
- What is the difference in meningococcal a conjugate (menga) vaccine immunization coverage (%) between Côte d'Ivoire and Nigeria?
- 2.0%, with Nigeria ahead.
- How many years of comparable data are there for Côte d'Ivoire and Nigeria?
- 10 years are reported by both, from 2016 to 2025.
- How do Côte d'Ivoire and Nigeria rank globally for meningococcal a conjugate (menga) vaccine immunization coverage (%)?
- Côte d'Ivoire ranks 12th and Nigeria ranks 11th of 26 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.